🇺🇸 FDA
Patent

US 8642539

Method for treating a disease characterized by reduced appetite

granted A61KA61K38/2221A61K39/3955

Quick answer

US patent 8642539 (Method for treating a disease characterized by reduced appetite) held by Takeda Pharmaceutical Company Limited expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/2221, A61K39/3955, A61P, A61P1/00